Hillsdale Investment Management’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-18,100
Closed -$423K 583
2016
Q3
$423K Hold
18,100
0.11% 185
2016
Q2
$362K Buy
18,100
+2,000
+12% +$37.3K 0.11% 203
2016
Q1
$273K Hold
16,100
0.09% 280
2015
Q4
$357K Buy
+16,100
New +$335K 0.14% 193
2015
Q1
Sell
-4,200
Closed -$44K 599
2014
Q4
$44K Buy
+4,200
New +$49.7K 0.01% 444

Other funds holding OME

Hillsdale Investment Management's OME Position: Q4 2016 in Review

Hillsdale Investment Management sold out of Omega Protein (OME) in Q4 2016, closing a stake of 18,100 shares — an estimated $423K sold.

Hillsdale Investment Management first reported a position in OME in Q4 2014 and held it in 5 quarters. The position peaked at $423K in Q3 2016. 142 funds tracked by Wall St. Rank hold OME as of Q4 2016.

  • Hillsdale Investment Management reported no remaining Omega Protein position as of Q4 2016 after selling out during the quarter.
  • Hillsdale Investment Management sold 18,100 Omega Protein shares in Q4 2016, an estimated $423K.
  • Hillsdale Investment Management first reported a position in Omega Protein in Q4 2014 and held it in 5 quarters.
  • Hillsdale Investment Management's Omega Protein position peaked at $423K in Q3 2016.
  • 142 funds tracked by Wall St. Rank held Omega Protein as of Q4 2016.

Based on Hillsdale Investment Management's 13F filing for Q4 2016, filed 13 Feb 2017.